Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of solithromycin for respiratory tract infections
jRCT2080223383Phase 3
- Sponsor
- Fujifilm
- Start
- Nov 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of solithromycin in Airways Infection, Chronic Respiratory Disease (CRD), acute bronchitis and 1 more, sponsored by Fujifilm.
02
Drugs
solithromycin
03
Conditions
Airways InfectionChronic Respiratory Disease (CRD)acute bronchitismycoplasma infection
Beyond the preview
Go deeper on jRCT2080223383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223383.